20:04 EST Cathie Wood’s ARK Investment bought 131K shares of Intellia Therapeutics today
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NTLA:
- Intellia Therapeutics Reveals Positive Phase 1 Results
- Intellia Therapeutics Announces Publication of Positive Interim Phase 1 Data for NTLA-2002 in Patients with Hereditary Angioedema in the New England Journal of Medicine
- Intellia Therapeutics announces publication of NTLA-2002 data in NEJM
- Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
- Intellia Therapeutics price target lowered to $80 from $93 at Stifel